Sr Talent Acquisition Manager at Axsome Therapeutics Inc

San Diego, California, United States

Apply Now

$140,000 – $175,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life Sciences, Technology, AIIndustries

Requirements

Bachelor's degree and 12+ years of experience as a full-cycle recruiter, or equivalent experience
Experience recruiting for Biotech and Technology companies and filling roles including Scientists, Software Engineers and Machine Learning
Proven track record of developing and managing both high-volume pipelines and specialty positions
Excellent time management, organizational skills and attention to detail
Outstanding communication skills, both written and verbal with ability to build and maintain strong rapport with candidates and internal stakeholders
Experience providing guidance, consultation and education to hiring managers on hiring process and best practices
Ability to work independently and collaboratively in a fast-paced environment
Experience managing applicant tracking systems, Ashby ATS preferred

Responsibilities

Own full life cycle recruiting end-to-end: posting roles, sourcing, screening, interviewing, reference checking and closing
Build and execute Iambic’s recruiting strategy across Software, AI/ML, Chemistry, Biology and Clinical roles
Serve as a strategic partner for leaders and hiring managers regarding recruiting plans and practices that support the goals of the organization
Manage and improve a repeatable recruiting process, pipeline reporting, and analytics to identify what’s working well and areas to improve
Source, engage, and close exceptional candidates in a competitive market with highly sought after roles
Utilize the applicant tracking system to its fullest extent, maintaining all pertinent application information and ensuring data integrity

Skills

Full Cycle Recruiting

Sourcing

Screening

Interviewing

Reference Checking

Pipeline Management

Applicant Tracking System

Recruiting Analytics

Biotech Recruiting

Technology Recruiting

AI/ML Recruiting

Chemistry Recruiting

Biology Recruiting

Clinical Recruiting

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free